Outlook Therapeutics OTLK
NASDAQ OTLK
$0.62 -0.01 (-0.91%)
As of: Sep 30, 2026 · 10:17 AM EDT

Outlook Therapeutics (OTLK) Gross Margin (2025)

Updated

Outlook Therapeutics (OTLK) posted Gross Margin of 4.05% for FY2025 (year ended Sep 30, 2025).

Analysis

Outlook Therapeutics (OTLK) Gross Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Outlook Therapeutics 84.78 Mn 49.03 Mn -8,265.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 70.78%
API Access

Outlook Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=OTLK&period=max&api_key=YOUR_API_KEY